Skip to main content
Log in

Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objective: Non-steroidal anti-inflammatory drugs (NSAIDs) have been consistently associated with reduced colon cancer risk. Associations with other cancer sites, particularly breast cancer, have been less consistent. This study's objective was to examine the relationship between use of non-prescription and prescription NSAIDs and breast cancer and carcinoma in situ of the breast. Methods: We analyzed data from a population-based, case–control study conducted in North Carolina between 1996 and 2000 to examine the association between NSAID use and breast cancer. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CI) separately for invasive breast cancer and carcinoma in situ of the breast. Findings: NSAID use was inversely associated with invasive breast cancer (multivariable adjusted OR = 0.4; 95% CI: 0.3–0.6). Inverse associations were apparent for both prescription and non-prescription medications, and for occasional as well as regular use of NSAIDs. Inverse associations also were observed with carcinoma in situ, however the effects were somewhat weaker. Interpretation: Our study adds to the accumulating, but somewhat inconsistent evidence that NSAIDs may reduce the risk of breast cancer. Future studies should work to define the most efficacious agents and determine whether genetic, lifestyle, or other characteristics influence their anti-carcinogenic properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baron JA,Sandler RS (2000) Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 51: 511-523.

    Google Scholar 

  2. Thun MJ,Henley SJ,Patrono C (2002) Nonsteroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266.

    Google Scholar 

  3. Jolly K,Cheng KK,Langman MJ (2002) NSAIDs and gastrointestinal cancer prevention. Drugs 62: 945-956.

    Google Scholar 

  4. Khuder SA,Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84: 1188-1192.

    Google Scholar 

  5. Paganini-Hill A,Chao A,Ross RK,Henderson BE (1989) Aspirin use and chronic diseases: a cohort study of the elderly. BMJ 299: 1247-1250.

    Google Scholar 

  6. Thun MJ,Namboodiri MM,Calle EE,Flanders WD,Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327.

    Google Scholar 

  7. Egan KM,Stampfer MJ,Giovannucci E,Rosner BA,Colditz GA (1996) Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst 88: 988-993.

    Google Scholar 

  8. Langman MJS,Cheng KK,Gilman EA,Lancashire RJ (2000) Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 320: 1642-1646.

    Google Scholar 

  9. Schreinemachers DM,Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138-146.

    Google Scholar 

  10. Harris RE,Namboodiri K,Stellman SD,Wynder EL (1995) Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Prev Med 24: 119-120.

    Google Scholar 

  11. Harris RE,Namboodiri KK,Farrar WB (1996) Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7: 203-205.

    Google Scholar 

  12. Harris RE,Kasbari S,Farrar WB (1999) Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 6: 71-73.

    Google Scholar 

  13. Neugut AI,Rosenberg DJ,Ahsan H, et al. (1998) Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 7: 869-873.

    Google Scholar 

  14. Coogan PF,Rao S,Rosenberg L, et al. (1999) The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. Prev Med 29: 72-76.

    Google Scholar 

  15. Cotterchio M,Kreiger N,Sloan M,Steingart A (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 1213-1217.

    Google Scholar 

  16. Sharpe CR,Collet J-P,McNutt M,Belzile E,Boivin J-F,Hanley JA (2000) Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 83: 112-120.

    Google Scholar 

  17. Newman B,Moorman PG,Millikan R, et al. (1995) The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35: 51-60.

    Google Scholar 

  18. Moorman PG,Grubber JM,Millikan RC,Newman B (2003) Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology 14: 307-314.

    Google Scholar 

  19. Weinberg CR,Sandler DP (1991) Randomized recruitment in case-control studies. Am J Epidemiol 134: 421-432.

    Google Scholar 

  20. Ouellet M,Percival MD (2001) Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys 387: 273-280.

    Google Scholar 

  21. Alshafie GA,Abou-Issa HM,Seibert K,Harris RE (2000) Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model. Oncol Rep 7: 1377-1381.

    Google Scholar 

  22. Hwang D,Scollard D,Byrne J,Levine E (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90: 455-460.

    Google Scholar 

  23. Han EK,Arber N,Yamamoto H, et al. (1998) Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Res Treat 48: 195-203.

    Google Scholar 

  24. Glue P,Clement RP (1999) Cytochrome P450 enzymes and drug metabolism-basic concepts and methods of assessment. Cell Mole Neurobiol 19: 309-323.

    Google Scholar 

  25. Guengerich FP (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39: 1-17.

    Google Scholar 

  26. Guillemette C,Millikan RC,Newman B,Housman DE (2000) Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African-Americans. Cancer Res 60: 950-956.

    Google Scholar 

  27. Bigler J,Whitton J,Lampe JW,Fosdick L,Bostick RM,Potter JD (2001) CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 61: 3566-3569.

    Google Scholar 

  28. London SJ,Daly AK,Leathart JB,Navidi WC,Idle JR (1996) Lung cancer risk in relation to the CYP2C9 * 1/CYP2C9 * 2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics 6: 527-533.

    Google Scholar 

  29. Monson RA,Bond CA (1978) The accuracy of the medical record as an index of outpatient drug therapy. JAMA 240: 2182-2184.

    Google Scholar 

  30. Stolley PD,Tonascia JA,Sartwell PE, et al. (1978) Agreement rates between oral contraceptive users and prescribers in relation to drug use histories. Am J Epidemiol 107: 226-235.

    Google Scholar 

  31. Cottler LB,Robins LN (1985) The effect of questionnaire design on reported prevalence of psychoactive medication. In: Harris LS, ed. Problems of Drug Dependence, 1984. NIDA Research Monograph 55, pp. 231-237.

  32. Beresford SAA,Coker AL (1989) Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol 130: 202-205.

    Google Scholar 

  33. Mitchell AA,Cottler LB,Shapiro S (1986) Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123: 670-676.

    Google Scholar 

  34. Top 200 Prescription Drugs. http://rxlist.com/top200.htm, accessed December 3, 2002.

  35. Chan TA (2002) Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol 3: 166-174.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia G. Moorman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moorman, P.G., Grubber, J.M., Millikan, R.C. et al. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes Control 14, 915–922 (2003). https://doi.org/10.1023/B:CACO.0000007973.59863.66

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:CACO.0000007973.59863.66

Navigation